Changing the Clinical Trials Game
We catch up with a new CEO and his goals for a clinical trials business
Stephanie Sutton | | Interview
Stepping up into the role of a CEO comes with new challenges and responsibilities. Stuart Young has been working in the clinical trials business for more than ten years – and recently landed the CEO spot at Panthera Biopartners in the UK. We caught up with Young about his new role – and his thoughts on how clinical trials can do better. With increasing scrutiny growing over drug prices, pharma manufacturers are looking for ways to reduce costs across the board. One area where there is vast room for improvement and optimization is in the clinical trials process – with many believing that new data management and other modern technologies could help.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.